⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
NOWRX INC. INVESTOR NOTICE: Squitieri Fearon LLP and Moore Law PLLC Announce that NowRx, Inc. Investors Have Opportunity to Lead Securities Class Action Lawsuit
prnewswire.com
NRXP
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
accessnewswire.com
RDZN
NRXP
AERT
CISO
ACXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
globenewswire.com
NRXP
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
globenewswire.com
NRXP
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group
accessnewswire.com
RDZN
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
globenewswire.com
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
globenewswire.com
NRXP
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine
accessnewswire.com
NRXP